MTOR and tuberous sclerosis: Additionally, small-molecule modulators such as mTOR inhibitors (e.g., Everolimus) have demonstrated neurocognitive benefits in individuals with tuberous sclerosis complex [109], illustrating the potential of disease-specific neuroprotective strategies.